Die Preise gelten nicht in den stationren Partnerapotheken
PYY is secreted by GI tract L-cells and carried throughout the gut
In clinical trials, this dual action has demonstrated greater glycemic control and weight reduction compared to specific selective GLP-1 receptor agonists such as semaglutide 1 mg in the SURPASS-2 trial
Parexel review of obesity trials planned, ongoing, or completed as of 2025 (unpublished data)
Moderator: - Sherif Guorgui, President, FIP Community Pharmacy Section, Canada Panellists: - Nisa Masyitah, FIP Project and Data Support Coordinator International Pharmaceutical Federation (FIP), Indonesia - Philip Conaghan, Director, NIHR Leeds Biomedical Research Centre University of Leeds, United Kingdom - Zanoli Gustavo, Orthopaedic Surgeon Casa Di Cura Santa Maria Maddalena, Occhiobello, Italy - Opeyemi Babatunde, Senior Lecturer: Evidence Synthesis and Applied Health Research School of Medicine, Primary Care Centre Versus Arthritis Keele University, Keele, Staffordshire, United Kingdom - Ema Paulino, President National Pharmacy Association (ANF), Portugal Watch video Digital event video 16 October 2024, 13:00 - 16:00 CEST Working together for the future of health care (Day 2) More The FIP Pharmacy Technician Advisory Committee (PTAC) invites you to attend the 2024 Pharmacy Technicians Symposium that will take place on 15 and 16 October to celebrate World Pharmacy Technician Day (15 October)
While some people may not lose as much weight on GLP-1 medications like semaglutide, they can still experience significant health benefits
